Primary objective of use of atropine in anterior uveitis
**Core Concept**
Atropine is an anticholinergic medication used in the management of anterior uveitis to reduce pain and prevent complications. The primary objective of using atropine in this condition is to cause mydriasis (pupil dilation) and cycloplegia (paralysis of the ciliary muscle), which helps to alleviate pain and prevent further inflammation.
**Why the Correct Answer is Right**
Atropine acts by competitively inhibiting the action of acetylcholine at muscarinic receptors in the eye, leading to relaxation of the iris sphincter muscle and dilation of the pupil. This reduces the amount of light entering the eye, which in turn reduces the pain caused by inflammation in the anterior uvea. Additionally, atropine prevents the ciliary muscle from contracting, which helps to prevent the formation of posterior synechiae (adhesions between the iris and the lens) and promotes the healing of the uvea.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while atropine does reduce pain, its primary objective in anterior uveitis is not to reduce pain alone, but to prevent complications such as posterior synechiae and promote healing.
**Option B:** This option is incorrect because atropine does not reduce inflammation directly, although it may help to prevent further inflammation by promoting healing of the uvea.
**Option C:** This option is incorrect because while atropine does cause mydriasis, its primary objective in anterior uveitis is not to dilate the pupil alone, but to prevent complications and promote healing.
**Clinical Pearl / High-Yield Fact**
It's essential to note that atropine should be used cautiously in patients with narrow-angle glaucoma, as it can cause further narrowing of the angle and increase intraocular pressure.
**Correct Answer:** C.